Avia Logo
Write a review

Products /

HPV L1 Antibodies for Neutralization and Vaccine Development

HPV L1 Antibodies for Neutralization and Vaccine Development

HPV L1 Antibodies for Neutralization and Vaccine Development

Visit Website

Visit Website

HPV L1 Antibodies for Neutralization and Vaccine Development
HPV L1 Antibodies for Neutralization and Vaccine Development

Visit Website

Overview


Select which hospital or health system you work at and see a personalized compatibility level.

Avia Summary

o
HPV L1 Antibodies for Neutralization and Vaccine Development is a solution provided by Creative Diagnostics. It belongs to multiple categories of digital health solutions including ED-based Mental Health Interventions and Diabetes Management.
DESCRIPTION

Human papillomavirus (HPV) is a virus from the papillomavirus family that is capable of infecting humans. Like all papillomaviruses, HPVs establish productive infections only in keratinocytes of the skin or mucous membranes. There are nearly 200 different strains of HPV, most of which are harmless and not cancer causing. Out of all these 14 high-risk HPV types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) are known to lead to cancers of the cervix, vulva, vagina, penis, oropharynx and anus, and another 6 are suspected of causing cancer. In addition, HPV has been linked with an increased risk of cardiovascular disease.

Read more
EHR integration

None provided
None provided
None provided
None provided
Use cases and differentiators

None provided
None provided
None provided
None provided
Company information

Media


Images

No images provided

Videos

No videos provided

Downloads

No content provided

Reviews


Filter reviews


Overall Score

0 review


Sort by:
Most Recent
Sort by:
Most Recent
Oldest
Most Helpful

Filter reviews


Reviewer’s Rating
5
4
3
2
1

Reviewer’s Role
  • End user
  • Project manager
  • IT / Technical support
  • Executive sponsor
  • Internal consultant
  • Other

Reviewer’s Org Size
  • XL ($5B+ NPR)
  • L ($3-5B NPR)
  • M ($1-3B NPR)
  • S ($0.2-1B NPR)
  • XS (< $0.2B NPR)

Reviewer’s Org EMR compatibility

Reviewer’s Org Type
  • AMC
  • Pediatric Facilities
  • ACO
  • Rural Presence


Clients


Filter clients


Type
  • Partner

  • Vendor

  • Health System

  • Other

back to top